The FDA has granted America Stem Cell approval to conduct a Phase I/IIa multicenter dual umbilical cord transplantation study. The nationwide trial will assess the efficacy of the firm's investigational therapy ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.
FDA gives green light to America Stem Cell transplant trial
SmartBrief Job Listings for Education
|K-12 Teachers Needed at Int’l Schools||
The International Educator
|Instructional Designer, ESL||
Imagine Learning, Inc.
|Sr. Product Manager - Professional Development||
|Sr. Product Manager - Formative Assessment Product Line||
|Multiple Locations, SL_Multiple Locations|